医学
放射治疗
预防性头颅照射
肺癌
阶段(地层学)
化疗
随机对照试验
前瞻性队列研究
外科
淋巴结
内科学
古生物学
心肌梗塞
传统PCI
生物
作者
Xiao Hu,Yong Bao,Yujin Xu,Li Zhang,Jin Wang,Honglian Ma,Ying Jin,Xiaoling Xu,Zhengbo Song,Fang Peng,Huarong Tang,Min Fang,Yue Kong,Mengyuan Chen,Baiqiang Dong,Xinmin Yu,Hongyang Lu,Yiping Zhang,Yun Fan,Ming Chen
标识
DOI:10.3760/cma.j.issn.1004-4221.2018.12.003
摘要
Objective
In view of the controversy over radiotherapy target volume for patients with limited-stage small cell lung cancer (SCLC), a prospective randomized controlled trial was conducted to compare the impact of different radiotherapy target volumes on prognosis.
Methods
After 2 cycles of EP chemotherapy, patients without progressive disease were randomly assigned to receive thoracic radiotherapy (TRT) to either the post-or pre-chemotherapy primary tumour extent as study arm or control. Involved field radiotherapy (IFRT) to the entire metastatic lymph node regions was applied for both arms. TRT consisted of 45 Gy/30Fx/19 d administered concurrently with cycle 3 chemotherapy. Prophylactic cranial irradiation was administered to patients achieved complete or partial remission. Kaplan-Meier method was used for survival analysis.
Results
Between June 2002 and December 2017, 159 and 150 patients were randomly assigned to study arm and control respectively. The 1-, 2-, and 5-year local/regional control rates were 79.4%, 61.5% and 60.1% respectively in the study arm versus 79.8%, 66.5%, and 57.3% in the control arm (P=0.73). The median OS time was 22.1 months in the study arm (95%CI, 18.2-26.0 months) and 26.9 months (95%CI, 23.5-30.3 months) in the control arm, the 1-, 3-, 5-, and 7-year OS rates were 81.1%, 31.6%, 23.9% and 22.2% respectively in the study arm versus 85.3%, 36.6%, 26.1% and 20.0% in the control arm (P=0.51). Grade 2-3 acute esophagitis was developed in 32.9% and 43.2% of patients respectively in study arm and control arm (P=0.01), while grade 2-3 pulmonary fibrosis was observed in 2.0% and 10.9% of patients (P=0.01) respectively.
Conclusions
For patients with limited-stage SCLC who received induction chemotherapy, thoracic radiotherapy can be limited to post-chemotherapy tumour extent and IFRT can be routinely applied.
Key words:
Lung neoplasms/radiotherapy; Radiotherapy target volume; Prospective study
科研通智能强力驱动
Strongly Powered by AbleSci AI